Financials
Financial year 2025
Gross margin
€ 0
Profit
Healthy€ 3,130
▼ 96% vs 2024
Debts
Low€ 2,100
▼ 73% vs 2024
UCB Belgium from Anderlecht, company number BE0402040254, closed financial year 2025 with a result of € 3,130 after tax. For that financial year UCB Belgium recorded a gross margin of € 0 and equity of € 4.1 million. Compared with financial year 2024, the result moved from € 79,955 to € 3,130. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 20, 2026.
What happened at UCB Belgium?
What happened at UCB Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Raf REMIJSEN stepped down as director. NBB
- Caroline VANCOILLIE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 3,130 (▼ 96% vs 2024). Source: NBB ↗
- Xavier HORMAECHEA stepped down as director. NBB
- Raf REMIJSEN became a director. NBB
- Caroline VANCOILLIE became a director. NBB
- Xavier HORMAECHEA became a director. NBB
- New establishment in Anderlecht. KBO
In short
From € 635 loss in 2021 to € 3,130 profit in 2025.
Paid € 215,806 in corporate taxes since 2021.
Best year ever: 2022, with € 80.3 million profit.
Paid out € 60.4 million in dividends to the owners in total.
A new publication or filing at UCB Belgium? We notify you, reason included.
Follow UCB BelgiumNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by UCB PHARMA SA (100%). It owns 100% of UCB FIPAR SA itself.
Directors
According to the 2025 annual accounts
Caroline VANCOILLIE
Director
since 2024 · until 2030
Raf REMIJSEN
Director
since 2025 · until 2031
Xavier HORMAECHEA
Managing director
since 2023 · until 2026
Shareholders
100%
Participations
100%
Establishments
Establishment units
Physical locations of this company
Researchdreef 60
1070 Anderlecht
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
U C B
UCB PHARMA same network
€ 4,622.6 million revenue · 2025
UCB Fipar same network
Fondation Emmanuel Janssen
UCB BIOPHARMA
€ 3,642.1 million revenue · 2025
+5 more
Details
- Company number
- 0402.040.254
- VAT number
- BE 0402.040.254
- Registered office
- Researchdreef 60, 1070 Anderlecht
- Names & denominations
- UCB Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 July 1919
- Peppol
- Active · Active since 12 Dec 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Overige ondersteunende activiteiten in verband met financiële diensten, neg, exclusief verzekeringen en pensioenfondsen